Some new oral anticoagulants (NOACs) are associated with an increased risk of intraocular hemorrhage, according to a new analysis of World Health Organization (WHO) data. Reuters Health Information
Ivantis secures $25 million in funding for commercialization of Hydrus microstent
Ivantis has secured $25 million in Series C funding for U.S. commercialization of the Hydrus microstent, according to a company press release.The Hydrus microstent, which is about the size of an eyelash, is expected to be approved by the FDA in 2018, the release said. It is designed to reduce a glaucoma patient’s IOP by re-establishing the natural outflow pathway, which is done through a minimally invasive microsurgical procedure.
Do You Have Dry Eye?
Did you know that tearing is actually a common symptom of dry eye? Here’s a review of the symptoms and causes of dry eye.
The post Do You Have Dry Eye? appeared first on Retina Specialist | Fairfax, Virginia | Retinal Diseases.
FDA approves Abbott’s iDesign for mixed astigmatism
The FDA has approved Abbott’s Star S4 IR excimer laser system and iDesign Advanced WaveScan Studio System for use in LASIK patients with mixed astigmatism, according to Abbott correspondence.The unequal curvature of the cornea in mixed astigmatism can cause one meridian of the eye to be farsighted while a second is nearsighted, the correspondence said. With the iDesign system, physicians can map the entire visual path to find the most beneficial treatment plan.
Mount Sinai creates eye and vision research institute
The Mount Sinai Health System has created a new eye and vision research institute, according to a press release.The Mount Sinai/New York Eye and Ear Eye and Vision Research Institute will focus on finding treatments and cures for eye conditions and dis…
Nikon, Verily partner to diagnose diabetic retinopathy sooner
Nikon Corp. and its subsidiary Optos Plc announced an alliance with Verily Life Science LLC in the field of machine learning-enabled retinal imaging, according to a press release. The companies will collaborate on creating technology and solutions for …